SAVID THERAPEUTICS INC has a total of 18 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2014. It filed its patents most often in China, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are IGENICA INC, DEV CT BIOTECHNOLOGY and BIOALLIANCE CV.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 5 | |
#2 | United States | 5 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Basic materials chemistry | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Pigments | |
#6 | Analysing materials | |
#7 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Mizohata Eiichi | 12 |
#2 | Shimizu Yohei | 12 |
#3 | Kawato Tatsuya | 12 |
#4 | Sugiyama Akira | 12 |
#5 | Kodama Tatsuhiko | 12 |
#6 | Kanai Motomu | 12 |
#7 | Doi Hirofumi | 12 |
#8 | Inoue Tsuyoshi | 11 |
#9 | Meshizuka Tomohiro | 11 |
#10 | Takatsu Mari | 8 |
Publication | Filing date | Title |
---|---|---|
CN109983024A | Scavenger | |
CN108752439A | Biotin variant, Streptavidin mutant and their application | |
EP2960243A1 | Biotin alterant, streptavidin mutant, and uses thereof |